The price-to-earnings ratio for NuVasive Inc. (NASDAQ: NUVA) is 148.77x, which is above its average ratio. Moreover, the 36-month beta value for NUVA is 1.08. Analysts have varying opinions on the stock, with 3 analysts rating it as a “buy,” 1 as “overweight,” 12 as “hold,” and 0 as “sell.”
The average price recommended by analysts for NuVasive Inc. (NUVA) is $49.06, which is $10.3 above the current market price. The public float for NUVA is 52.02M and currently, short sellers hold a 9.47% of that float. On May 24, 2023, NUVA’s average trading volume was 966.46K shares.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Sponsored
NUVA) stock’s latest price update
The stock price of NuVasive Inc. (NASDAQ: NUVA) has dropped by -3.88 compared to previous close of 40.24. Despite this, the company has seen a fall of -5.34% in its stock price over the last five trading days. Barron’s reported on 02/09/23 that Globus Medical to Buy NuVasive in $3.1 Billion Deal
NUVA’s Market Performance
NuVasive Inc. (NUVA) has experienced a -5.34% fall in stock performance for the past week, with a -10.21% drop in the past month, and a -12.03% drop in the past quarter. The volatility ratio for the week is 2.77%, and the volatility levels for the past 30 days are at 2.30% for NUVA. The simple moving average for the past 20 days is -7.33% for NUVA’s stock, with a -9.62% simple moving average for the past 200 days.
NUVA Trading at -5.50% from the 50-Day Moving Average
After a stumble in the market that brought NUVA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -33.94% of loss for the given period.
Volatility was left at 2.30%, however, over the last 30 days, the volatility rate increased by 2.77%, as shares sank -9.33% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -0.18% lower at present.
During the last 5 trading sessions, NUVA fell by -5.34%, which changed the moving average for the period of 200-days by -24.85% in comparison to the 20-day moving average, which settled at $41.54. In addition, NuVasive Inc. saw -6.21% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for NUVA
Current profitability levels for the company are sitting at:
- +6.94 for the present operating margin
- +60.04 for the gross margin
The net margin for NuVasive Inc. stands at +3.36. The total capital return value is set at 4.54, while invested capital returns managed to touch 2.52. Equity return is now at value 2.40, with 0.90 for asset returns.
Based on NuVasive Inc. (NUVA), the company’s capital structure generated 115.79 points at debt to equity in total, while total debt to capital is 53.66. Total debt to assets is 45.23, with long-term debt to equity ratio resting at 63.07. Finally, the long-term debt to capital ratio is 29.23.
When we switch over and look at the enterprise to sales, we see a ratio of 2.35, with the company’s debt to enterprise value settled at 0.32. The receivables turnover for the company is 5.18 and the total asset turnover is 0.55. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.21.
Conclusion
To wrap up, the performance of NuVasive Inc. (NUVA) has been bad in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
